Amphastar Pharmaceuticals
AMPH
$41.86
Share price
-1.37%
Change (1 day)
0.24%
Change (1 year)
Categories
Earnings for Amphastar Pharmaceuticals (AMPH)
Earnings in 2023 (TTM): $0.19 B
According to Amphastar Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $0.19 B. In 2022 the company made an earning of $0.11 B an increase over its 2021 earnings that were of $85.02 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Amphastar Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $0.19 B | 68.4% |
| 2022 | $0.11 B | 38.65% |
| 2021 | $85.02 M | 1596.75% |
| 2020 | $5.01 M | -91.7% |
| 2019 | $60.34 M | -723.23% |
| 2018 | -$9.69 M | -516.29% |
| 2017 | $2.32 M | -85.44% |
| 2016 | $15.97 M | -270.31% |
| 2015 | -$9.38 M | -46.53% |
| 2014 | -$17.54 M | -196.44% |
| 2013 | $18.18 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | -$0.12 B | -159.63% | 🇺🇸 USA |
 SCYNEXIS SCYX | $70.3 M | -64.58% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | -$0.15 B | -172.01% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$13.05 M | -106.57% | 🇺🇸 USA |